Eulogio Conde García-rekin lankidetzan egindako argitalpenak (8)

2012

  1. Outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 4, Núm. 1

2005

  1. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: A multicenter study by the PETHEMA Group

    Journal of Clinical Oncology, Vol. 23, Núm. 30, pp. 7632-7640

2004

  1. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy

    Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1404-1412

2003

  1. Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: Results from APL 93 trial

    Leukemia, Vol. 17, Núm. 2, pp. 339-342

  2. Imatinib mesylate as treatment for blastic transformation of Philadelphia chromosome positive chronic myelogenous leukemia

    Haematologica, Vol. 88, Núm. 11, pp. 1213-1220

2002

  1. CsA-based post-graft immunosuppression: The main factor for improving outcome of allografted patients with acquired aplastic anemia: A retrospective survey by the Spanish Group of Hematopoietic Transplantation

    Bone Marrow Transplantation, Vol. 29, Núm. 3, pp. 205-211

2001

  1. Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: The role of preparative regimens

    Bone Marrow Transplantation, Vol. 27, Núm. 4, pp. 405-412

1998

  1. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia

    Blood, Vol. 92, Núm. 8, pp. 2712-2718